Immunize.org supports evidence-based vaccination recommendations and schedules. Read more at About Us.

Clinical Resources: Standing Orders Templates

Results (4)

Standing Orders for Administering Nirsevimab RSV Preventive Antibody (Beyfortus, by Sanofi) to Infants and High-Risk Young Children

Eligible healthcare professionals may vaccinate all infants and high-risk young children who meet the criteria established by the American Academy of Pediatrics (AAP) in September 2026 (https://doi.org/10.1542/peds.2026-079047), for immunization with a long-acting preventive antibody against RSV (nirsevimab, brand name Beyfortus, by Sanofi), with information provided on current CDC recommendations.

#P3097
Updated on: 9/14/26
Language: English

This page was updated on .

Our Affiliated Sites

For the Public: VaccineInformation.org
For Coalitions: ImmunizationCoalitions.org
Let's Get Real
Information about pediatric vaccines for parents and providers.
65+ Flu Defense
Protect vulnerable, older adult patients from influenza.
Give2MenACWY.org
Improve protection from meningococcal serogroups ACWY.
NAIIS
Home of the National Adult and Influenza Immunization Summit.